(Q38870287)

7 September 2017

title

Interferon-induced Parkinsonism in a patient with chronic hepatitis C. (English)

1 reference

7 September 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

author name string

Carlos Mauricio Oliveira de Almeida

1

1 reference

7 September 2017

Maria de Lourdes de Souza Galvão

2

1 reference

7 September 2017

Paulo Luis da Costa Ferreira

3

1 reference

7 September 2017

Wornei Silva Braga

4

1 reference

7 September 2017

publication date

1 September 2009

1 reference

Arquivos de Neuro-Psiquiatria

7 September 2017

published in

1 reference

7 September 2017

volume

67

1 reference

7 September 2017

issue

3A

1 reference

7 September 2017

page(s)

715-716

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Sequence analysis of the 5' noncoding region of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Treating viral hepatitis C: efficacy, side effects, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Persistent neurotoxicity of systemically administered interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Neurologic toxicity associated with interferon alpha therapy for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

A pilot study of ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

The effect of ribavirin on bone density in patients with chronic hepatitis C treated with interferon-ribavirin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

Recombinant interferon-α–induced chorea and frontal subcortical dementia: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2009000400031

10.1590/S0004-282X2009000400031

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference